Business Context and Reporting Period
Alzamend Neuro, Inc. (ALZN), an emerging growth company incorporated in Delaware, filed this Form 8-K on September 8, 2023. The report details the entry into a material definitive agreement to raise capital through an at-the-market (ATM) equity offering.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or debt levels. The primary financial metric disclosed is the potential capital raise:
- Aggregate Offering Price: Up to approximately $9.8 million.
- Security Type: Common Stock, $0.0001 par value.
- Sales Agent: Ascendiant Capital Markets, LLC.
Material Changes
The material change reported is the execution of an At-the-Market Issuance Sales Agreement on September 8, 2023. This agreement allows the company to sell shares from time to time through an ATM offering pursuant to Rule 415 under the Securities Act of 1933. The offering is conducted under an effective shelf registration statement (No. 333-273610) filed on August 2, 2023.
Guidance, Outlook, and Risks
Management Commentary and Terms: The company retains control over sales parameters, including the number of shares, timing, daily limits, and minimum price thresholds. Both the company and the agent may suspend or terminate the agreement at any time upon written notice.
Risks and Contingencies: The filing notes that the offer is not valid in any state where such an offer would be unlawful prior to registration. The document explicitly states it does not constitute an offer to sell or a solicitation of an offer to buy the shares.
Investor Verification Checklist
- Verify the current share price and potential dilution impact of selling up to $9.8 million in shares.
- Review the full text of the At-The-Market Issuance Sales Agreement (Exhibit 10.1) for specific termination clauses and fee structures.
- Confirm the company's current cash position and burn rate to assess the necessity of this capital raise.
- Check subsequent filings to determine if and when shares have actually been sold under this agreement.